An overview of the anti-SARS-CoV-2 properties of Artemisia annua, its antiviral action, protein-associated mechanisms, and repurposing for COVID-19 treatment
- 22 July 2021
- journal article
- review article
- Published by Elsevier BV in Journal of Integrative Medicine
- Vol. 19 (5), 375-388
- https://doi.org/10.1016/j.joim.2021.07.003
Abstract
No abstract availableKeywords
This publication has 74 references indexed in Scilit:
- Ethnopharmacology in overdrive: The remarkable anti-HIV activity of Artemisia annuaJournal of Ethnopharmacology, 2012
- A reporter system for Epstein-Barr virus (EBV) lytic replication: Anti-EBV activity of the broad anti-herpesviral drug artesunateJournal of Virological Methods, 2011
- PAK1 as a therapeutic targetEmerging Therapeutic Targets, 2010
- Flavonoids from Artemisia annua L. as Antioxidants and Their Potential Synergism with Artemisinin against Malaria and CancerMolecules, 2010
- The Antiviral Activities of Artemisinin and ArtesunateClinical Infectious Diseases, 2008
- Anti-malarial agent artesunate inhibits TNF- -induced production of proinflammatory cytokines via inhibition of NF- B and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytesRheumatology, 2007
- Virtual screening for finding natural inhibitor against cathepsin-L for SARS therapyAmino Acids, 2006
- Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocationInternational Immunopharmacology, 2006
- Biosafety Level 3 Laboratory for Autopsies of Patients with Severe Acute Respiratory Syndrome: Principles, Practices, and ProspectsClinical Infectious Diseases, 2005
- Identification of natural compounds with antiviral activities against SARS-associated coronavirusAntiviral Research, 2005